(E)-heptacos-19-enoic acid - Compound Card

(E)-heptacos-19-enoic acid

Select a section from the left sidebar

(E)-heptacos-19-enoic acid

Structure
Zoomed Structure
  • Family: Plantae - Tiliaceae
  • Kingdom: Plantae
  • Class: Lipid
    • Subclass: Fatty Acid
Canonical Smiles CCCCCCC/C=C/CCCCCCCCCCCCCCCCCC(=O)O
InChI InChI=1S/C27H52O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-27(28)29/h8-9H,2-7,10-26H2,1H3,(H,28,29)/b9-8+
InChIKey ZLXHCUCFRRNHGW-CMDGGOBGSA-N
Formula C27H52O2
HBA 1
HBD 1
MW 408.71
Rotatable Bonds 24
TPSA 37.3
LogP 9.62
Number Rings 0
Number Aromatic Rings 0
Heavy Atom Count 29
Formal Charge 0
Fraction CSP3 0.89
Exact Mass 408.4
Number of Lipinski Rule Violations 1
# Species Family Kingdom NCBI Taxonomy ID
1 Duboscia macrocarpa Tiliaceae Plantae 3105915

Showing of synonyms

  • Kamdem RST, Wafo P, et al. (2018). Bioactive chemical constituents of Duboscia macrocarpa Bocq., and X-ray diffraction study of 11β, 12β-epoxyfriedours-14-en-3α-ol.. Fitoterapia,2018, 125, 65-71. [View] [PubMed]
Pubchem: 170315572

No compound-protein relationship available.

No scaffolds available.

Anti-alpha-glucosidase

Absorption

Caco-2 (logPapp)
-4.89
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.01
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-3.21

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
2.12
Plasma Protein Binding
49.59
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
0.47
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Safe
Bioconcentration Factor
1.17
Biodegradation
Toxic
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Toxic
Maximum Tolerated Dose
1.98
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
3.99
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-2.1
Rat (Acute)
1.64
Rat (Chronic Oral)
2.84
Fathead Minnow
4.28
Respiratory Disease
Toxic
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
454.45
Hydration Free Energy
-3.41
Log(D) at pH=7.4
5.41
Log(P)
12.05
Log S
-5.12
Log(Vapor Pressure)
-9.2
Melting Point
75.0
pKa Acid
6.04
pKa Basic
8.27
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
thiamine diphosphokinase Q82ZE3 Q82ZE3_ENTFA Enterococcus faecalis 3 0.9479
Sodium/potassium-transporting ATPase subunit alpha Q4H132 Q4H132_SQUAC Squalus acanthias 2 0.7301
Isopenicillin N synthase P05326 IPNS_EMENI Emericella nidulans 2 0.7101

Download SDF